SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Viveve Medical, Inc. (VIVE) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 27/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — VIVE
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.00
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-2.65
Book Value / Share$0.00
Revenue / Share$0.64
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2012 |
$-209,675.00 |
$1.08M |
$-8.39M |
-776.6% |
| 2013 |
$22,429.00 |
$1.27M |
$3.5M |
274.6% |
| 2014 |
$-2,744.23 |
$90K |
$-6.18M |
-6866.7% |
| 2015 |
$-2,474.31 |
$1.45M |
$-12.43M |
-858.7% |
| 2016 |
$-2,180.76 |
$7.14M |
$-20.11M |
-281.6% |
| 2017 |
$-2,093.62 |
$15.29M |
$-36.63M |
-239.6% |
| 2018 |
$-1,583.50 |
$18.52M |
$-49.18M |
-265.6% |
| 2019 |
$-374.40 |
$6.57M |
$-46.72M |
-711.4% |
| 2020 |
$-13.50 |
$5.48M |
$-21.24M |
-387.6% |
| 2021 |
$-2.65 |
$6.43M |
$-22.03M |
-342.8% |
